Karl Hsu

Karl Hsu is a seasoned professional in global drug development, particularly in the hematology and oncology sectors. Currently serving as Senior Vice President of Clinical Research and Early Development at Zai Lab since April 2020, Karl leads various development functions and has extensive experience in early development, clinical pharmacology, and translational medicine. Prior to this, Karl held significant positions at Sanofi, including Head of Oncology Development Strategy and Science and Associate Vice President, Global Head of Early Development Oncology, where responsibilities encompassed global development strategies within oncology. Karl's earlier career included key roles at Merck as Director of Clinical Oncology, focusing on clinical trials, and academic positions at Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center. Karl completed medical education at the University of Pennsylvania School of Medicine and holds a BA in Biochemistry from Case Western Reserve University.